Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/1996
02/20/1996US5493007 Oligopeptide
02/20/1996US5493006 Cyclic CRF analogs
02/20/1996US5492920 Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
02/20/1996US5492916 Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
02/20/1996US5492896 Pseudopeptides having an antiviral action
02/20/1996US5492895 Inhibitors of thrombosis
02/20/1996US5492893 Sterilization of animals; therapy od sex hormone relateddiseases
02/20/1996US5492892 Endothelin antagonists
02/20/1996US5492891 Treating with human growth hormone to increase levels of insulin-like growth factor
02/20/1996US5492890 Polypeptides for promoting cell attachment
02/20/1996US5492889 Treatment of mast cell tumors
02/20/1996US5492825 Mammalian inward rectifier potassium channel cDNA, IRK1, corresponding vectors, and transformed cells
02/20/1996US5492822 Passing solution of dialyzed pancreatic cytosol over column of hydroxyapatite, passing single peak eluted over gel filtration column, dialyzing eluted single peak, passing over column containing heparin-agarose or -sepharose, washing, collecting
02/20/1996US5492809 Mutations rendering platelet glycoprotein Ib-α less reactive
02/20/1996US5492808 Means for detecting familial colon cancer (FCC)
02/20/1996US5492689 Administering simultaneously an antiviral agent and two antiinflammatory compounds; synergistic result in treatment of cold or influenza
02/20/1996US5492314 Preloaded digressive rate mount
02/20/1996CA2018211C Modified hvi-type hirudin and process for the manufacture thereof
02/20/1996CA1338079C Adhesion protein micelles
02/20/1996CA1338077C Heterodimeric transforming growth factor-beta
02/17/1996CA2156132A1 Recombinant vectors derived from adenovirus for use in gene therapy
02/15/1996WO1996004397A1 Gene therapy using homologous recombination
02/15/1996WO1996004395A1 Recombinant virus vectors
02/15/1996WO1996004394A1 Hsv viral vector
02/15/1996WO1996004389A1 Rtk/cytokine receptor chimeras
02/15/1996WO1996004388A1 Novel compounds
02/15/1996WO1996004387A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme
02/15/1996WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
02/15/1996WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
02/15/1996WO1996004384A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression
02/15/1996WO1996004383A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression
02/15/1996WO1996004381A1 S. aureus fibronectin binding protein polypeptides and uses thereof
02/15/1996WO1996004380A1 D2d3 polypeptide from staphylococcus aureus and uses thereof
02/15/1996WO1996004378A2 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2
02/15/1996WO1996004377A1 Production of tissue factor pathway inhibitor
02/15/1996WO1996004376A1 Hepatitis a virus receptor and methods of use
02/15/1996WO1996004375A1 Retrovirus-induced osteoclast modulation for osteoporosis therapy
02/15/1996WO1996004372A1 Ikaros transgenic cells and animals
02/15/1996WO1996004314A1 Mhc complexes and uses thereof
02/15/1996WO1996004313A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
02/15/1996WO1996004311A1 Monoclonal antibody to nitrotyrosine, methods for diagnosis and methods for treatment of disease
02/15/1996WO1996004310A1 Contraceptive vaccine
02/15/1996WO1996004308A1 Cyclic hexapeptide somatostatin analogues
02/15/1996WO1996004307A1 Aspb1 insulin analogs
02/15/1996WO1996004306A2 Muteins of mammalian cytokines
02/15/1996WO1996004305A1 Hybrid molecules useful in the treatment of tumors, their preparation and use in pharmaceutical compositions
02/15/1996WO1996004304A1 Fibrin-binding peptides, dna coding therefor and uses thereof
02/15/1996WO1996004303A1 Protein having anti-retrovirus activity and method for obtaining it
02/15/1996WO1996004302A1 Novel tumor marker for lung cancer
02/15/1996WO1996004300A1 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection
02/15/1996WO1996004299A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same
02/15/1996WO1996004298A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same
02/15/1996WO1996004294A1 Nucleic acid to initiate the activity of ribonuclease h or reverse transcriptase
02/15/1996WO1996004242A1 Arylthio compounds as antibacterial and antiviral agents
02/15/1996WO1996004013A1 Use of il-6 to treat toxic shock
02/15/1996WO1996004012A1 Use of the combination of chlorpromazine plus interleukin-6 to treat or prevent septic shock
02/15/1996WO1996004011A2 Novel compound to mimic a naturally occurring peptide's effect
02/15/1996WO1996004010A1 Vr-2332 viral nucleotide sequence and methods of use
02/15/1996WO1996004008A1 Treatment of cancer with human chorionic gonadotropin
02/15/1996WO1996004007A1 Methods for treating addictive disorders
02/15/1996WO1996004006A1 USE OF AT LEAST ONE FORM OF THE β2-GLYCOPROTEIN I AS AN ANTI-INFECTIOUS AGENT AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
02/15/1996WO1996004005A1 Pharmaceutical compositions containing extracted mhc molecules, for stimulation of the immune system
02/15/1996WO1996004004A1 Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular diseases
02/15/1996WO1996004003A1 Use of fibronectin binding proteins in oral hygiene
02/15/1996WO1996004002A1 Remedy for corneal diseases
02/15/1996WO1996003993A2 Modulation of thymocyte and t cell functional activity
02/15/1996WO1996003987A1 Lactone compounds for treating patients with precancerous lesions
02/15/1996WO1996003984A1 Controlled local delivery of chemotherapeutic agents for treating solid tumors
02/15/1996WO1996003982A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors
02/15/1996WO1996003981A1 Growth stimulating factors
02/15/1996WO1996003883A1 Cells bearing cd4 decoy receptors and related molecules and methods
02/15/1996WO1996002645A3 Htk ligand
02/15/1996WO1996000586A3 Methods for treating cell proliferative disorders by modulating signal transduction
02/15/1996WO1995034650A3 Mn gene and protein
02/15/1996WO1995032285A3 Transgenic arthritic mice
02/15/1996DE4428402A1 Gentherapeutisches Verfahren unter Verwendung von DNA-Vektoren ohne Selektionsmarker-Gen Gene therapy methods using DNA vectors without selectable marker gene
02/15/1996DE4426259A1 Medical use of angiotensin-converting enzyme inhibitor
02/15/1996DE3891231C2 Astigmatism correcting laser surgical set
02/15/1996CA2328638A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression
02/15/1996CA2196748A1 Treatment of cancer with human chorionic gonadotropin
02/15/1996CA2196687A1 Corneal therapeutic agent
02/15/1996CA2196569A1 Aspb1 insulin analogs
02/15/1996CA2196450A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same
02/15/1996CA2196290A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2
02/15/1996CA2196285A1 Contraceptive vaccine
02/15/1996CA2196200A1 Novel compounds
02/15/1996CA2196195A1 Methods and compositions for differential diagnosis of acute and chronic hepatitis c virus infection
02/15/1996CA2196190A1 Ikaros transgenic cells and animals
02/15/1996CA2196183A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors
02/15/1996CA2196168A1 Recombinant virus vectors
02/15/1996CA2196102A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same
02/15/1996CA2195965A1 Hsv viral vector
02/15/1996CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
02/15/1996CA2193845A1 Arylthio compounds as antibacterial and antiviral agents
02/15/1996CA2172710A1 Lactone compounds for treating patients with precancerous lesions
02/15/1996CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
02/14/1996EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus
02/14/1996EP0696639A1 Use of interferon gamma for the inhibition of proliferation and differentiation of primitive hematopoietic progenitor cells
02/14/1996EP0696595A1 Low temperature albumin fractionation using sodium caprylate as a partitioning agent
02/14/1996EP0696594A1 Human interleukin 6 inhibitor
1 ... 2803 2804 2805 2806 2807 2808 2809 2810 2811 2812 2813 2814 2815 2816 2817 2818 2819 2820 2821 2822 2823 ... 3163